Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-6-16
pubmed:abstractText
Hemopoietic cells or bone marrow-derived cells contribute to tissue formation, possibly by transdifferentiation into smooth muscle cells (SMCs) or myofibroblasts. In this study our goal is to examine the effects of transforming growth factor-beta1 (TGF-beta1) on the transdifferentiation of the monocyte/macrophage lineage into SMC-like cells. Using rat peritoneal exudate macrophages, we investigated the expression of smooth muscle-specific differentiation markers, such as alpha-smooth muscle actin, embryonic smooth muscle myosin heavy chain, and calponin. The treatment of macrophages with TGF-beta1 enhanced the expression of SMC-specific markers at day 4; after 7 days in culture, a higher level of expression (approximately 3- to 5-fold) was detected on Western blots. In contrast, TGF-beta1 decreased the expression of CD11b, which is a macrophage marker. Furthermore, we examined the effect of the TGF-beta type 1 receptor inhibitor SB-431542 and a replication-defective adenovirus construct expressing Smad7 (Adeno-Smad7), which inhibits TGF-beta signaling by interfering with the activation of other Smad proteins. Both SB-431542 and Adeno-Smad7 suppressed the expression of SMC-specific markers. These results indicated that TGF-beta signaling is essential for the transdifferentiation of macrophages into SMC-like cells. Elucidating the mechanism by which macrophages transdifferentiate into SMC-like cells may reveal new therapeutic targets for preventing vascular diseases.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0916-9636
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
269-76
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16778334-Adenoviridae, pubmed-meshheading:16778334-Animals, pubmed-meshheading:16778334-Antigens, Surface, pubmed-meshheading:16778334-Benzamides, pubmed-meshheading:16778334-Biological Markers, pubmed-meshheading:16778334-Cell Differentiation, pubmed-meshheading:16778334-Cells, Cultured, pubmed-meshheading:16778334-Dioxoles, pubmed-meshheading:16778334-Dose-Response Relationship, Drug, pubmed-meshheading:16778334-Genetic Vectors, pubmed-meshheading:16778334-Macrophages, Peritoneal, pubmed-meshheading:16778334-Male, pubmed-meshheading:16778334-Myocytes, Smooth Muscle, pubmed-meshheading:16778334-Rats, pubmed-meshheading:16778334-Rats, Sprague-Dawley, pubmed-meshheading:16778334-Signal Transduction, pubmed-meshheading:16778334-Smad7 Protein, pubmed-meshheading:16778334-Transforming Growth Factor beta, pubmed-meshheading:16778334-Transforming Growth Factor beta1
pubmed:year
2006
pubmed:articleTitle
Transforming growth factor-beta signaling enhances transdifferentiation of macrophages into smooth muscle-like cells.
pubmed:affiliation
Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
pubmed:publicationType
Journal Article